Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY-NC 4.0Journal of Alzheimer's Disease Reports

A newly defined substage of late-stage Alzheimer's disease, the “Dementia Gap”: Can sedation to unconsciousness to relieve patients' intolerable suffering be moral?

  1. 1Caring Advocates, Sausalito, CA, USA

Abstract

Advanced Alzheimer's disease is a terminal illness causing more intense, prolonged suffering than clinicians generally recognize. At least 500,000 Americans are trapped in the “Dementia Gap”, a previously unidentified substage of advanced dementia. Patients lack capacity to voluntarily stop eating and drinking but can still eat and drink independently, making “dementia-specific” living wills ineffective until further disease progression requires assistance with oral feeding and hydrating. Additionally, patients experience “Non-Observable Suffering”: inner emotional angst, inexpressible physical pain, and bi-directional suffering shared with loved ones. A dangerous non sequitur fallacy can lead casual observers to extrapolate peaceful inner states from withdrawn external behavior: “She's not suffering; she's just sitting there.” To effectively relieve intolerable suffering, this article introduces “Moderate Anesthesia”—palliative sedation to unconsciousness modified to be clearly distinguishable from euthanasia. Cases demonstrate moral justification grounded in Sulmasy's “Reinvented Rule of Double Effect,” “Parsimonious Direct Sedation,” or the Principle of Proportionality. Two Dementia Gap patients the author treated are compared with two advanced cancer patients. Two withdrawn patients “awakened” through skillful interviewing, exemplifying this ethical warning: diligent efforts to detect and relieve non-observable suffering should precede implementing treatments of last resort. The article presents the “Three-Source Concordance” protocol using an illustrated patient decision aid and polling Patient Decision Committee members’ substituted judgments to confirm the clinical appropriateness of implementing POLSTs that patients completed during advance care planning. A 42% cumulative lifetime dementia risk means many of us may reach the Dementia Gap. Launching the ARISE movement—Advocate by Recognizing and Investigating Suffering's (hidden) Existence—and convening expert panels to develop practice guidelines are moral imperatives.

Related

  1. Association of Nut Consumption with Dementia and Alzheimer’s Disease
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  2. Paired CSF–Plasma Analyte Signal Contrasts Across Alzheimer’s Disease Clinical Stages and MCI-to-Dementia Conversion
    Yuepeng Deng, Dandan Chen, Haolin Yin +3
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Brief report: Alzheimer’s disease and related dementia in intellectually disabled people in the United States
    Salina Tewolde, Samuel B. Rosenberg, Marcia Pescador Jimenez +1
    American journal on intellectual and developmental disabilitiesPeer-reviewedLicence not statedFull textPsychiatry & mental healthPMC
  4. Sex‐specific brain reserve and progression from mild cognitive impairment to Alzheimer's disease dementia
    Xulin Liu, Sterre C. M. de Boer, Maria Carmela Tartaglia
    Alzheimer's & dementia : the journal of the Alzheimer's AssociationPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Blood Biomarkers of Alzheimer's Disease Neuropathology, Cognition, and Response to a Multidomain Lifestyle Intervention: Secondary analysis of the FINGER Randomized Controlled Dementia Risk Reduction Trial
    A. Rosenberg, A. Solomon, A. Matton +13
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
BibTeX
@article{terman2026newly,
  title = {{A newly defined substage of late-stage Alzheimer's disease, the “Dementia Gap”: Can sedation to unconsciousness to relieve patients' intolerable suffering be moral?}},
  author = {Stanley A. Terman},
  journal = {Journal of Alzheimer's Disease Reports},
  year = {2026},
  month = jul,
  doi = {10.1177/25424823261460085},
  url = {https://doi.org/10.1177/25424823261460085},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - A newly defined substage of late-stage Alzheimer's disease, the “Dementia Gap”: Can sedation to unconsciousness to relieve patients' intolerable suffering be moral?
AU  - Stanley A. Terman
PY  - 2026
DA  - 2026/07/08
JO  - Journal of Alzheimer's Disease Reports
DO  - 10.1177/25424823261460085
UR  - https://doi.org/10.1177/25424823261460085
AB  - Advanced Alzheimer's disease is a terminal illness causing more intense, prolonged suffering than clinicians generally recognize. At least 500,000 Americans are trapped in the “Dementia Gap”, a previously unidentified substage of advanced dementia. Patients lack capacity to voluntarily stop eating and drinking but can still eat and drink independently, making “dementia-specific” living wills ineffective until further disease progression requires assistance with oral feeding and hydrating. Additionally, patients experience “Non-Observable Suffering”: inner emotional angst, inexpressible physical pain, and bi-directional suffering shared with loved ones. A dangerous non sequitur fallacy can lead casual observers to extrapolate peaceful inner states from withdrawn external behavior: “She's not suffering; she's just sitting there.” To effectively relieve intolerable suffering, this article introduces “Moderate Anesthesia”—palliative sedation to unconsciousness modified to be clearly distinguishable from euthanasia. Cases demonstrate moral justification grounded in Sulmasy's “Reinvented Rule of Double Effect,” “Parsimonious Direct Sedation,” or the Principle of Proportionality. Two Dementia Gap patients the author treated are compared with two advanced cancer patients. Two withdrawn patients “awakened” through skillful interviewing, exemplifying this ethical warning: diligent efforts to detect and relieve non-observable suffering should precede implementing treatments of last resort. The article presents the “Three-Source Concordance” protocol using an illustrated patient decision aid and polling Patient Decision Committee members’ substituted judgments to confirm the clinical appropriateness of implementing POLSTs that patients completed during advance care planning. A 42% cumulative lifetime dementia risk means many of us may reach the Dementia Gap. Launching the ARISE movement—Advocate by Recognizing and Investigating Suffering's (hidden) Existence—and convening expert panels to develop practice guidelines are moral imperatives.
SN  - 2542-4823
ER  -